Navigation Links
FASEB announces the 2011 Summer Research Conference series: Registration is now open
Date:2/17/2011

Bethesda, MD - Since 1982, the FASEB SRC's have offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.

FASEB has announced 37 SRCs planned for the summer of 2011. Series topics include:

  • Microbial Polysaccharides of Medical, Agricultural, & Industrial Importance
  • Regulation & Function of Small GTPases
  • Proteases in Hemostasis & Vascular Biology
  • From Unfolded Proteins in the Endoplasmic Reticulum to Disease
  • The Molecular & Cellular Origins & the Biomedical Consequences of Protein Aggregation
  • Ion Channel Regulation
  • Biology & Chemistry of Vision
  • Mechanism & Regulation of Procaryotic Transcription
  • Signal Transduction in the Immune System
  • Molecular, Structural & Clinical Aspects of Vitamin K & Vitamin K Dependent Proteins
  • Polycystic Kidney Disease: From Bench to Bedside
  • Melatonin Receptors: Actions & Therapeutics
  • Histone Deacetylases & Reversible Acetylation in Signaling & Disease
  • Nutritional Immunology: Role in Health & Disease
  • Autoimmunity
  • Ciliate Molecular Biology
  • Molecular Mechanisms of Immune Cell Development & Function
  • Dynamic Regulation of Membrane-Based Processes by Tetraspanins & Other Scaffold Proteins
  • Protein Kinases & Protein Phosphorylation
  • Mitochondrial Assembly & Dynamics in Health, Disease & Aging
  • Probiotics, Intestinal Microbiota & the Host: Physiological & Clinical Implications
  • Protein Lipidation, Signaling, & Membrane Domains
  • Microbial Pathogenesis: Mechanisms of Infectious Disease
  • Genetic Recombination & Genome Rearrangements
  • Translational Neuroimmunology: From Mechanisms to Therapeutics
  • Hematopoietic Malignancies
  • Epigenetics, Chromatin & Transcription
  • Helicases & Nucleic Acid Translocases: Stucture, Mechanism, Function, & Roles in Human Diseases
  • Intracellular RNA Transport & Localized Translation (An EMBO, FASEB sponsored conference)
  • Mobile DNA in Mammalian Genomes
  • Nutrient Control of Metabolism & Cell Signaling
  • Lysophospholipid Mediators in Health & Disease
  • Glucose Transporters, Signaling, & Diabetes
  • Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation & Cancer
  • The TGF- Superfamily: Signaling in Development & Diseases
  • NAD Metabolism & Signaling
  • Transcriptional Elongation in Health & Disease

And new in 2011, FASEB has created individual event pages on Facebook and LinkedIn to help facilitate online collaboration prior to the meeting and beyond. This way, attendees can continue intimate discussions on these specialized topics even after the conference has ended. A listing of these event pages can be found at www.FASEB.org/SRC.


'/>"/>

Contact: Julie Levin
SRC@FASEB.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
2. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
3. FASEB alert generates messages urging Congress to provide billion dollar increase for NIH
4. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
5. NIAID announces 25 new awards to develop radiation countermeasures
6. Aware Announces Q3 2008 Earnings Conference Call
7. Governor Doyle announces historic genomic research collaboration
8. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
9. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
10. Parkinsons Disease Foundation announces award of $150,000
11. Jefferson Department of Surgery announces new pancreas tumor registry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: